Business
Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025
Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment